BTG (BTG) Share Price, News & Analysis

Company Overview

BTG is a leading financial and real estate advisory group. We use our expertise to enhance, protect, and realise the value of our clients’ businesses, assets, and investments. Turning complexity into clarity, we support clients in funding and delivering their projects and navigating periods of challenge and change. We operate across eight seamless service lines, each combining to support our clients throughout every stage of their business’s lifecycle. • Restructuring – Restructuring and recovery services supporting businesses through challenges, opportunities, realising value, and regaining control • Financial Advisory – Expert advice for success: developing strategy, evolving leadership, optimising profitability, and maximising capital • Deal Advisory – End-to-end deal expertise de-risking and improving deals for strategic growth or exit through M&As • Funding and Insurance – Tailored finance and insurance solutions driving sustainable success and protecting your business • Agency and Auctions – Expert agency and auction services quickly unlocking property, business, and asset value • Projects and Developments – Planning and delivering bespoke building solutions that help you achieve your property goals • Property Management and Insurance – Insuring and ensuring property portfolio performance through expert management services • Valuations and Asset Advisory – RICS-certified valuations and asset advisory delivering confidence in value across lease and asset strategy With over 1,400 experts working across 50+ UK locations as well as 5 offshore offices, we connect our clients to a national network of expertise. At BTG, we don't just advise - we act, putting our expertise into action.

Key Stats

• Today's Range: 120 to 124
• 50-Day Range: 115 to 121.50
• 52-Week Range: 110 to 124
• Volume: 8,361 shs
• Average Volume: 287,061 shs
• Market Capitalization: £193.85 million
• P/E Ratio: 20.06
• Dividend Yield: 3.62%
• Price Target: GBX 162.50
• Consensus Rating: Buy

BTG Stock Analysis - MarketRank™

BTG scored higher than 80% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.1 / 5
• Analyst Rating: Buy

Consensus Rating

BTG has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

BTG has a consensus price target of GBX 162.50, representing about 34.3% upside from its current price of GBX 121.

Amount of Analyst Coverage

BTG has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of BTG is 20.17, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.78.

Price to Earnings Ratio vs. Sector

The P/E ratio of BTG is 20.17, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 21.22.

Price to Book Value per Share Ratio

BTG has a P/B Ratio of 0.34. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for BTG.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

BTG is a leading dividend payer. It pays a dividend yield of 3.62%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

BTG does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of BTG is 71.67%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 1.1 / 5
• News Sentiment: -0.18

News Sentiment

BTG has a news sentiment score of -0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for BTG this week, compared to 6 articles on an average week.

Search Interest

Only 23 people have searched for BTG on MarketBeat in the last 30 days. This is a decrease of -15% compared to the previous 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, BTG insiders have not sold or bought any company stock.

Percentage Held by Insiders

19.77% of the stock of BTG is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

19.25% of the stock of BTG is held by institutions.

Company Calendar

• Last Earnings: 5/15/2018
• Today: 5/26/2026

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Precious Metals
• Current Symbol: LON:BTG
• CIK: N/A
• Web: www.btgplc.com
• Phone: +44-20-75750000
• Fax: N/A
• Employees: 4,690
• Year Founded: N/A

Price Target and Rating

• Average Price Target for BTG: GBX 162.50
• High Price Target: GBX 165
• Low Price Target: GBX 160
• Potential Upside/Downside: +35.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 20.06
• Forward P/E Ratio: 2.67
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.05
• Quick Ratio: 2.19

Sales & Book Value

• Annual Sales: £159.40 million
• Price / Sales: 1.22
• Cash Flow: GBX 13.01 per share
• Price / Cash Flow: 9.25
• Book Value: GBX 355.80 per share
• Price / Book: 0.34

Miscellaneous

• Outstanding Shares: 161,051,000
• Free Float: N/A
• Market Cap: £193.85 million
• Optionable: Not Optionable
• Beta: N/A